AGECURVE LIMITED

Dear East Coast investors, 15-20 October I'll be in Manhattan and 20-26 I'll be in D.C. and very happy to arrange personal meetings to discuss AGECURVE LIMITED's existing assets aligned with our future plans to build a complete and validated pipeline in order to provide Individualised aging diagnostics and therapeutics for all #longevity #aging #AI #singlecellsequencing

AGECURVE LIMITED was accepted into the prestigious NVIDIA #Inception program to build human #aging/#longevity #deeplearning #AI systems from multi-modal, single-cell data

Issac Emmanuel Goh started last week at AGECURVE LIMITED as a Senior Computational Biologist and Translational Geroscientist Extraordinaire, his expertise covers single cell transcriptomics, the biology of the hematopoietic system and the latest/greatest AI methods, the local Cambridge Team has now 4 people, just the amount needed to deliver the next milestones! #longevity #geroscience #singlecellsequencing #genomics #transcriptomics #AI

happy to see AGECURVE LIMITED included in this year's #21toWatch Companies list by @cofinitive https://lnkd.in/eCTY9z9E

Geroscience startup, AgeCurve has secured a £250k investment to further develop its novel next generation ageing diagnostic tool, which aims to provide important clues to treat ageing at its root causes. https://lnkd.in/e-2sRwdx The industry-developed Cell Tree Rings tracker promises to deliver a smarter, cheaper way of measuring scalable single cell somatic mutation burden and more accurately pinpoint biological age for improved clinical longevity interventions. The funding, which has come from a private Central European investment firm, will be used to achieve three milestones – to develop a licensable Cell Tree Rings product for the ageing diagnostics sector, for ageing therapeutics and for cell therapy. AGECURVE LIMITED founder and CEO, Attila Csordas says: “We have an evolutionary method through the cell trees to measure, in an unbiased way, the somatic mutation burden that accumulates with age, even in healthy people. “Our comprehensive system works as a human single cell somatic mutation tracker and ageing timer to accurately pinpoint biological age at the fundamental genome instability level, and help build future ageing clocks which can better predict life expectancy, morbidity and mortality. “This is an essential solution which the longevity industry and its private clinics want now – and this knowledge about somatic mutations will contribute meaningfully to new longevity medicines, ageing therapeutics and future geroprotective drugs. And, in five years’ time, demand will be even more widespread.” “We want to apply a disruptive method which is commercially tied to the most commercially available single cell sequencing platform, and apply it across the whole life sciences ecosystem. “Right now, we are working on one project to run a beta study for cell therapy application to cut the cost of cell therapy manufacturing, make it safer and possibly improve efficacy too. “The uses for the Cell Tree Rings are considerable. We can track the clonal history of cells, and it can also be used as a general quality control tool for safe drug efficacy testing.” AgeCurve, which is based at ideaSpace City in Cambridge, has filed UK and PCT patents for Cell Tree Rings as a method and cell lineage tree based ageing timer for calculating biological age of a biological sample, and is currently working with the Prague and Florida-based HealthyLongevity.clinic . Last year, Attila underwent the University of Cambridge’s 12-week entrepreneurship programme, impulse, Maxwell Centre, which helps unique individuals keep focus and turn their innovations or ventures to the point where they can become a viable business.

this job position is still open at AGECURVE LIMITED in the heart of Cambridge, in the middle of the new and exciting longevity industry https://lnkd.in/e_tR25ay

if you ever want to use your single cell sequencing and quantitative skills to actually work on technology that can help extend healthy lifespans and lead to improved therapies, this on-site Senior Computational Biologist position at #Cambridge, UK is one such opportunity, you'd work next to my office table, here's your future view https://lnkd.in/erxUn4Ye #job